Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Advocacy: 2019 Year in Review

Blair Solow, MD  |  January 5, 2020

How you can help:  Send a letter to Congress showing your support.

As we look ahead in 2020, the ACR government affairs team will be tackling several issues:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Implementing the E/M payment increases for 2021
  2. Tracking proposals related to drug pricing
  3. Advancing legislation in the areas of:
    1. Utilization management, including prior authorization and step therapy;
    2. Workforce/loan repayment; and
    3. NIH/DOD funding for rheumatology research.
  4. Tracking changes to MACRA and the new MIPS Value Pathways (MVPs)
  5. Addressing issues such as DXA and musculoskeletal ultrasound reimbursement
  6. Monitoring other legislation that could affect our members, such as congressional proposals to control surprise billing

Advocates for Arthritis
Each year I ask several patients to consider applying for the Advocates for Arthritis meeting so they can see firsthand what it is like to travel to D.C. to advocate. I let them know this meeting will give them the opportunity to speak to members of Congress and congressional aides and share their experiences.

In 2019, I was fortunate to have a physician patient join me, and he was inspired and surprised by what he learned behind the scenes in D.C. He connected the implications of legislation to both his practice of medicine and his experience as a patient. Advocates for Arthritis let him speak to legislators about his personal experience with limited access to and delays in seeing a rheumatologist, his access to biologic medications being restricted by insurance despite his position as a practicing ENT surgeon and knowledge of payer issues, his appreciation of the time spent in the room with me discussing treatment options, and his concern over the rise in price of medications. He learned how to tweet, which was amplified by his social media-savvy daughters.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

These Hill visits with him illuminated what the College accomplished in 2019.

Thank you for your time, efforts, enthusiasm and perseverance. I am looking forward to an ongoing conversation about how advocacy and health policy affects you and your patients and how you can help.

Wishing you and yours a Happy New Year!


Blair Solow, MD, is chair of the ACR Government Affairs Committee and an assistant professor of medicine in the Division of Rheumatic Diseases at UT Southwestern Medical Center in Dallas.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Blair SolowGovernment Affairs Committee (GAC)legislation and advocacy

Related Articles

    Payments Cut to the Bone

    February 1, 2007

    CMS reduces reimbursement for DXA and vertebral fracture assessment

    ACR Advocacy: 2020 Year in Review

    January 11, 2021

    As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.

    The ACR’s 2020 Advocacy Year in Review

    February 16, 2021

    To say it has been an interesting (the science and the memes), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that we hope have kept everyone going.  As we look to 2021, we take lessons from our experiences in 2020. Washington,…

    Reading Rheum

    May 1, 2009

    Handpicked Reviews of Contemporary Literature

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences